Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

IRIDEX Corp

IRIX ✓ COMPLIANT ☆ Track — members

NASDAQ · Healthcare · Advanced Medical Equipment & Technology ·

USA Micro Cap Analyst: BUY

Last Close

$0.61

▼ -4.03%

Market Cap $10.66M · Vol 13.39K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$10.66M

Micro Cap

Div Yield

N/A

EPS Growth

+53.85%

YoY

RSI (14)

16.80

Momentum

Beta

0.70

vs Market

52W High

$1.64

62.99% below

52W Low

$0.61

0.00% above

Volume

13.39K

Avg 19.82K

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

63.18%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, IRIDEX Corp (IRIX) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does IRIX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-10.74%

-29.09%

-48.99%

-54.36%

YTD

-46.75%

-52.58%

-69.95%

-91.41%

Financials & Valuation

TTM · Annual

Total Revenue	$52.68M
Net Income	$-4,437,000.00
Revenue Growth (YoY)	-7.41%
Gross Margin	36.50%
Operating Margin	-4.88%
Net Profit Margin	-8.42%
ROE	N/A
ROA · ROIC	-15.03% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	0.38
P/B	N/A
P/FCF	N/A
EPS Growth	+53.85%
Outstanding Shares	17.56M

Technical Indicators

50-Day SMA	$0.83
200-Day SMA	$1.09
RSI (14)	16.80
Beta	0.70
52-Week High	$1.64
52-Week Low	$0.61

Volume Today	13.39K
Avg Daily Volume (30D)	19.82K
Relative Volume	0.68x
Volatility (10D)	20.25
Volatility (30D)	63.08
Free Float	63.18%

Analyst Consensus

BUY

Current Price $0.61

Mean Target $2.75

52W Low$0.61 52W High$1.64

Current

Target

$0.61 $1.64

Current Analyst target

+353.05% upside potential · 1 analysts

Identifiers

ExchangeNASDAQ

FIGIBBG001S7J0Y3

ISINUS4626841013

CountryUSA

Sub-IndustryAdvanced Medical Equipment & Technology (NEC)

Earnings DateNov 9, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

TMO Thermo Fisher Scientific Inc +1.10% DHR Danaher Corporation -0.48% ISRG Intuitive Surgical, Inc. +1.36% BSX Boston Scientific Corp +0.09% EW Edwards Lifesciences Corporation +4.13%

Company Profile

IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.